Nicolas JP, Lin Y, Lambeau G, Ghomashchi F, Lazdunski M, Gelb MH (Mar 1997). "Localization of structural elements of bee venom phospholipase A2 involved in N-type receptor binding and neurotoxicity". The Journal of Biological Chemistry272 (11): 7173–81. PMID9054413. doi:10.1074/jbc.272.11.7173.
De Luca D, Minucci A, Cogo P, Capoluongo ED, Conti G, Pietrini D, Carnielli VP, Piastra M (Jan 2011). "Secretory phospholipase A₂ pathway during pediatric acute respiratory distress syndrome: a preliminary study". Pediatric Critical Care Medicine12 (1): e20–4. PMID20351613. doi:10.1097/PCC.0b013e3181dbe95e.
Ezzeddini R, Darabi M, Ghasemi B, Jabbari Moghaddam Y, Jabbari Y, Abdollahi S, Rashtchizadeh N, Gharahdaghi A, Darabi M, Ansarin M, Shaaker M, Samadi A, Karamravan J (Apr 2012). "Circulating phospholipase-A2 activity in obstructive sleep apnea and recurrent tonsillitis". International Journal of Pediatric Otorhinolaryngology76 (4): 471–4. PMID22297210. doi:10.1016/j.ijporl.2011.12.026.
Six DA, Dennis EA (Oct 2000). "The expanding superfamily of phospholipase A(2) enzymes: classification and characterization". Biochimica Et Biophysica Acta1488 (1-2): 1–19. PMID11080672. doi:10.1016/S1388-1981(00)00105-0.
Berg OG, Gelb MH, Tsai MD, Jain MK (Sep 2001). "Interfacial enzymology: the secreted phospholipase A(2)-paradigm". Chemical Reviews101 (9): 2613–54. PMID11749391. doi:10.1021/cr990139w. See page 2640
Leslie CC (Jul 1997). "Properties and regulation of cytosolic phospholipase A2". The Journal of Biological Chemistry272 (27): 16709–12. PMID9201969. doi:10.1074/jbc.272.27.16709.
Farooqui AA, Ong WY, Horrocks LA (Sep 2006). "Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders". Pharmacological Reviews58 (3): 591–620. PMID16968951. doi:10.1124/pr.58.3.7.
Bell JG, MacKinlay EE, Dick JR, MacDonald DJ, Boyle RM, Glen AC (Oct 2004). "Essential fatty acids and phospholipase A2 in autistic spectrum disorders". Prostaglandins, Leukotrienes, and Essential Fatty Acids71 (4): 201–4. PMID15301788. doi:10.1016/j.plefa.2004.03.008.
Nicolas JP, Lin Y, Lambeau G, Ghomashchi F, Lazdunski M, Gelb MH (Mar 1997). "Localization of structural elements of bee venom phospholipase A2 involved in N-type receptor binding and neurotoxicity". The Journal of Biological Chemistry272 (11): 7173–81. PMID9054413. doi:10.1074/jbc.272.11.7173.
De Luca D, Minucci A, Cogo P, Capoluongo ED, Conti G, Pietrini D, Carnielli VP, Piastra M (Jan 2011). "Secretory phospholipase A₂ pathway during pediatric acute respiratory distress syndrome: a preliminary study". Pediatric Critical Care Medicine12 (1): e20–4. PMID20351613. doi:10.1097/PCC.0b013e3181dbe95e.
Ezzeddini R, Darabi M, Ghasemi B, Jabbari Moghaddam Y, Jabbari Y, Abdollahi S, Rashtchizadeh N, Gharahdaghi A, Darabi M, Ansarin M, Shaaker M, Samadi A, Karamravan J (Apr 2012). "Circulating phospholipase-A2 activity in obstructive sleep apnea and recurrent tonsillitis". International Journal of Pediatric Otorhinolaryngology76 (4): 471–4. PMID22297210. doi:10.1016/j.ijporl.2011.12.026.
Six DA, Dennis EA (Oct 2000). "The expanding superfamily of phospholipase A(2) enzymes: classification and characterization". Biochimica Et Biophysica Acta1488 (1-2): 1–19. PMID11080672. doi:10.1016/S1388-1981(00)00105-0.
Berg OG, Gelb MH, Tsai MD, Jain MK (Sep 2001). "Interfacial enzymology: the secreted phospholipase A(2)-paradigm". Chemical Reviews101 (9): 2613–54. PMID11749391. doi:10.1021/cr990139w. See page 2640
Leslie CC (Jul 1997). "Properties and regulation of cytosolic phospholipase A2". The Journal of Biological Chemistry272 (27): 16709–12. PMID9201969. doi:10.1074/jbc.272.27.16709.
Farooqui AA, Ong WY, Horrocks LA (Sep 2006). "Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders". Pharmacological Reviews58 (3): 591–620. PMID16968951. doi:10.1124/pr.58.3.7.
Bell JG, MacKinlay EE, Dick JR, MacDonald DJ, Boyle RM, Glen AC (Oct 2004). "Essential fatty acids and phospholipase A2 in autistic spectrum disorders". Prostaglandins, Leukotrienes, and Essential Fatty Acids71 (4): 201–4. PMID15301788. doi:10.1016/j.plefa.2004.03.008.